Transine Therapeutics
biotechnology company
Transine Therapeutics has raised €16M across 1 funding round from 3 investors, most recently a Seed round in Jun 2022. Based in Cambridge, UK; active in Healthtech. Data as of Nov 2026.
Cambridge, UKwww.transinetx.com ↗
Total raised
€16M
€16,087,743
Funding rounds
1
Investors
3
distinct backers
Active since
2022-06
latest 2022-06
Funding by year
EUR raised per yearTransine Therapeutics — funding by year — interactive chart.
Data table
| Transine Therapeutics — funding by year | |
|---|---|
| 2022 | €16M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-01 | Seed | €16M | Dementia Discovery Fund (DDF),Epidarex Capital,Mary Canning | View deal → |
Related news
- Transine Therapeutics Closes £13.7M in Seed Fundingfinsmes.com · 2022-06
Similar companies
same sector, similar size- Epitopea€12MUK · Healthtech
- Shift Bioscience€15MUK · Healthtech
- Optellum€16MUK · Healthtech
- Feel€15MUK · Healthtech
- ExpressionEdits€12MUK · Healthtech
- Gaia€18MUK · Healthtech
Global coverage: FundingData